申请人:SEATTLE GENETICS, INC.
公开号:US20170232112A1
公开(公告)日:2017-08-17
Disclosed are formulations, including both liquid and lyophilized formulations, comprising a benzodiazepine antibody-drug conjugate (ADC) and a cyclodextrin. Also disclosed are methods of purifying mixtures comprising benzodiazepine antibody-drug conjugates and process drug-related impurities.